Investor Day 2025
Logotype for Ingredion Incorporated

Ingredion (INGR) Investor Day 2025 summary

Event summary combining transcript, slides, and related documents.

Logotype for Ingredion Incorporated

Investor Day 2025 summary

8 Jul, 2026

Strategic vision and transformation

  • Transitioned from an ingredients company to a solutions provider, focusing on value creation, disciplined capital allocation, risk management, and operational excellence.

  • Pursuing business transformation through portfolio optimization, innovation, and cost competitiveness to strengthen market leadership and maximize shareholder returns.

  • Completed business resegmentation, divested non-core assets, and achieved record EBITDA, EPS, and cash, exceeding prior growth targets.

  • Achieved record 2024 results: adjusted diluted EPS of $10.65 (+13% YoY), $1.4B cash from operations (+36% YoY), and gross profit margin of 24.1% (+270bps YoY).

  • Emphasizes global reach with local expertise, leveraging deep customer relationships and diversified product mix across 16,000 customers in 22 countries.

Segment performance and growth outlook

  • Texture and Healthful Solutions segment targets 4%-6% net sales growth and 28%-30% gross profit margins, with 8%-10% adjusted operating income CAGR (2025-2027), driven by clean label and innovation.

  • LATAM segment leverages a century-long presence, local manufacturing, and a broad portfolio to target 2%-3% net sales growth and 26%-28% gross margins, with 5%-6% adjusted operating income CAGR.

  • US-Canada segment focuses on stable cash generation, margin expansion (21%-23% gross margin), and portfolio diversification, targeting 0%-1% net sales CAGR and 1%-2% adjusted operating income CAGR.

  • Industrial applications and sustainable packaging are growth areas, with investments in biodegradable binders and PFAS-free solutions.

  • The 'Other' segment, including protein fortification and sugar reduction, is improving profitability and expected to contribute more significantly.

Innovation and operational excellence

  • R&D investments focus on texture science, clean label, sugar reduction, protein technology, and AI-driven predictive formulation.

  • Over 500 R&D associates in 30 labs drive $300M in annual new product sales, with 3% of Texture and Healthful Solutions sales reinvested in R&D.

  • Proprietary data and advanced imaging techniques enable faster, more successful product launches and co-creation with customers.

  • Launched new clean label texturizing fibers and piloted first-to-market texture solutions service.

  • Operational excellence initiatives, including global procurement and supply chain optimization, have delivered millions in savings and improved service metrics.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more